JP2024506182A5 - - Google Patents

Info

Publication number
JP2024506182A5
JP2024506182A5 JP2023547852A JP2023547852A JP2024506182A5 JP 2024506182 A5 JP2024506182 A5 JP 2024506182A5 JP 2023547852 A JP2023547852 A JP 2023547852A JP 2023547852 A JP2023547852 A JP 2023547852A JP 2024506182 A5 JP2024506182 A5 JP 2024506182A5
Authority
JP
Japan
Prior art keywords
pyran
hydroxy
carboxamide
triazole
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023547852A
Other languages
English (en)
Japanese (ja)
Other versions
JP7844491B2 (ja
JP2024506182A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/052948 external-priority patent/WO2022171594A1/en
Publication of JP2024506182A publication Critical patent/JP2024506182A/ja
Publication of JP2024506182A5 publication Critical patent/JP2024506182A5/ja
Application granted granted Critical
Publication of JP7844491B2 publication Critical patent/JP7844491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023547852A 2021-02-09 2022-02-08 ヒドロキシヘテロシクロアルカン-カルバモイル誘導体 Active JP7844491B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2021053084 2021-02-09
EPPCT/EP2021/053084 2021-02-09
PCT/EP2022/052948 WO2022171594A1 (en) 2021-02-09 2022-02-08 Hydroxyheterocycloalkane-carbamoyl derivatives

Publications (3)

Publication Number Publication Date
JP2024506182A JP2024506182A (ja) 2024-02-09
JP2024506182A5 true JP2024506182A5 (cg-RX-API-DMAC7.html) 2025-02-17
JP7844491B2 JP7844491B2 (ja) 2026-04-13

Family

ID=80445748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547852A Active JP7844491B2 (ja) 2021-02-09 2022-02-08 ヒドロキシヘテロシクロアルカン-カルバモイル誘導体

Country Status (13)

Country Link
US (1) US12304902B2 (cg-RX-API-DMAC7.html)
EP (1) EP4291556B1 (cg-RX-API-DMAC7.html)
JP (1) JP7844491B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230145111A (cg-RX-API-DMAC7.html)
CN (1) CN116806219A (cg-RX-API-DMAC7.html)
AU (1) AU2022221092A1 (cg-RX-API-DMAC7.html)
CA (1) CA3207214A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002322A1 (cg-RX-API-DMAC7.html)
ES (1) ES3032987T3 (cg-RX-API-DMAC7.html)
IL (1) IL304923A (cg-RX-API-DMAC7.html)
TW (1) TW202246248A (cg-RX-API-DMAC7.html)
WO (1) WO2022171594A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202308643B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
US12404295B2 (en) 2019-08-09 2025-09-02 Idorsia Pharmaceuticals Ltd (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
WO2022073969A1 (en) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100172D0 (sv) 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
IN2015DN02573A (cg-RX-API-DMAC7.html) 2012-10-31 2015-09-11 Galecto Biotech Ab
EP2919802A4 (en) 2012-11-15 2016-09-14 Univ Tufts METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
CA2970062C (en) 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
ES2734713T3 (es) 2015-07-06 2019-12-11 Gilead Sciences Inc Moduladores Cot y métodos de utilización de los mismos
CN109563119A (zh) 2016-07-12 2019-04-02 格莱克特生物技术公司 半乳糖凝集素的α-D-半乳糖苷抑制剂
CA3062649A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the treatment of systemic insulin resistance disorders and the use thereof
KR102626669B1 (ko) 2017-05-12 2024-01-17 갈랙틴 사이언시즈, 엘엘씨 질환의 예방 및 치료를 위한 화합물 및 이의 용도
US11267811B2 (en) 2017-09-27 2022-03-08 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
WO2019075045A1 (en) 2017-10-11 2019-04-18 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
JP2021501180A (ja) 2017-10-31 2021-01-14 ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニーGalectin Sciences, LLC 全身インスリン抵抗性障害の治療のためのセレノガラクトシド化合物およびその使用
CN113366007A (zh) 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
CN113286632A (zh) 2018-10-15 2021-08-20 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂前药
US11447517B2 (en) 2018-11-21 2022-09-20 Galecto Biotech Ab Galactoside inhibitor of galectins
US12269819B2 (en) 2019-04-10 2025-04-08 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3
JP7674276B2 (ja) 2019-07-03 2025-05-09 ガレクト バイオテック エービー ガレクチンの新規なガラクトシド阻害剤
CA3143078A1 (en) 2019-07-05 2021-01-14 Galecto Biotech Ab Novel galactoside inhibitor of galectins
US12404295B2 (en) 2019-08-09 2025-09-02 Idorsia Pharmaceuticals Ltd (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
WO2022073969A1 (en) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
WO2022184755A1 (en) 2021-03-03 2022-09-09 Idorsia Pharmaceuticals Ltd Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives

Similar Documents

Publication Publication Date Title
JP2023547241A5 (cg-RX-API-DMAC7.html)
US12370194B2 (en) Metalloenzyme inhibitor compounds
JP2022544248A5 (cg-RX-API-DMAC7.html)
JP2024509421A5 (cg-RX-API-DMAC7.html)
JP2022546029A5 (cg-RX-API-DMAC7.html)
AU2018202865B2 (en) Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JP2023545046A5 (cg-RX-API-DMAC7.html)
JP2022530049A5 (cg-RX-API-DMAC7.html)
ES2398606T3 (es) Derivados de 2-piridin-carboxamida como moduladores de los canales de sodio
ME02053B (me) Oksazol supstituisani indazoli kao inhibitori pi3-kinaze
JP2022543859A5 (cg-RX-API-DMAC7.html)
JP2019533694A5 (cg-RX-API-DMAC7.html)
JP2022554169A5 (cg-RX-API-DMAC7.html)
JP2020189882A (ja) Mekインヒビターおよびその使用方法
EP2699557B1 (en) 3-(oxazol-2-yl-ethoxy)- and 3-(thiazol-2-yl-ethoxy)-benzamide derivatives as anti-bacterial agents
JP2010508307A5 (cg-RX-API-DMAC7.html)
US20150225389A1 (en) Therapeutic compounds and compositions
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2005538955A5 (cg-RX-API-DMAC7.html)
CN112262139A (zh) 作为激酶抑制剂的氨基吡咯并三嗪
JP2014521696A5 (cg-RX-API-DMAC7.html)
TWI807300B (zh) 二唑衍生物化合物及包含其的藥物組合物
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2023506357A5 (cg-RX-API-DMAC7.html)
US20210171475A1 (en) Compounds